NO166569C - Fremgangsmaate til fremstilling av farmasoeytisk preparat inneholdende fosfolipider og ikke-steroidale antiflogistika. - Google Patents

Fremgangsmaate til fremstilling av farmasoeytisk preparat inneholdende fosfolipider og ikke-steroidale antiflogistika.

Info

Publication number
NO166569C
NO166569C NO844889A NO844889A NO166569C NO 166569 C NO166569 C NO 166569C NO 844889 A NO844889 A NO 844889A NO 844889 A NO844889 A NO 844889A NO 166569 C NO166569 C NO 166569C
Authority
NO
Norway
Prior art keywords
preparation
antiflogistics
steroid
procedure
containing phospholipids
Prior art date
Application number
NO844889A
Other languages
English (en)
Norwegian (no)
Other versions
NO844889L (no
NO166569B (no
Inventor
Armin Wendel
Helmut Wetzig
Manfred Duerr
Sigurd Leyck
Joerg Hager
Miklos Ghyczy
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of NO844889L publication Critical patent/NO844889L/no
Publication of NO166569B publication Critical patent/NO166569B/no
Publication of NO166569C publication Critical patent/NO166569C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO844889A 1983-12-22 1984-12-06 Fremgangsmaate til fremstilling av farmasoeytisk preparat inneholdende fosfolipider og ikke-steroidale antiflogistika. NO166569C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3346526A DE3346526C2 (de) 1983-12-22 1983-12-22 Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen

Publications (3)

Publication Number Publication Date
NO844889L NO844889L (no) 1985-06-24
NO166569B NO166569B (no) 1991-05-06
NO166569C true NO166569C (no) 1991-08-14

Family

ID=6217768

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844889A NO166569C (no) 1983-12-22 1984-12-06 Fremgangsmaate til fremstilling av farmasoeytisk preparat inneholdende fosfolipider og ikke-steroidale antiflogistika.

Country Status (24)

Country Link
US (1) US4687766A (ko)
EP (1) EP0147735B1 (ko)
JP (1) JPS60169420A (ko)
KR (1) KR920003602B1 (ko)
AT (1) ATE40793T1 (ko)
AU (1) AU566974B2 (ko)
CA (1) CA1234049A (ko)
DD (1) DD233076A5 (ko)
DE (2) DE3346526C2 (ko)
DK (1) DK619484A (ko)
EG (1) EG17137A (ko)
ES (1) ES8707111A1 (ko)
FI (1) FI83287C (ko)
GR (1) GR82545B (ko)
HU (1) HU193729B (ko)
IL (1) IL73849A (ko)
IN (1) IN162327B (ko)
MX (1) MX159874A (ko)
NO (1) NO166569C (ko)
NZ (1) NZ210648A (ko)
OA (1) OA07907A (ko)
PH (1) PH21823A (ko)
PT (1) PT79649B (ko)
ZA (1) ZA849976B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5763422A (en) * 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
AUPN766496A0 (en) * 1996-01-22 1996-02-15 University Of New England, The Method and composition for the potentiation of anti-inflammatory drugs
PL371626A1 (en) * 2002-01-21 2005-06-27 Vasogen Ireland Limited Pharmaceutically acceptable phosphate-glycerol carrying bodies
WO2003090757A1 (en) * 2002-04-26 2003-11-06 Rudolf Perl Pharmaceutical compositions of phospholipid derivatives
EP1658086A2 (en) * 2003-07-21 2006-05-24 Vasogen Ireland Limited Liposomes containing phosphate glycerol groups for treating acute inflammatory condition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3787324A (en) * 1971-03-01 1974-01-22 Warner Lambert Co 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production
FR2343481A1 (fr) * 1976-03-11 1977-10-07 Gerlich Norbert Composition destinee a empecher les lesions des membranes biologiques et a regenerer ces membranes une fois qu'elles ont ete endommagees
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
JPS54117034A (en) * 1978-02-28 1979-09-11 Nippon Shoji Kk Treating agent for consciousness and perception motion disorder
DE2856333C2 (de) * 1978-12-27 1983-09-22 A. Nattermann & Cie GmbH, 5000 Köln Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung
DE2856339C2 (de) * 1978-12-27 1985-12-05 Fortuna-Werke Maschinenfabrik Gmbh, 7000 Stuttgart Vorrichtung zum kontinuierlichen, automatischen Zustellen von Setzstockbacken zur Halterung eines Werkstückes auf einer Rundschleifmaschine
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
DE3047048A1 (de) * 1980-12-13 1982-07-29 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von oel und/oder phosphatidylethanolamin aus diese enthaltenden alkoholloeslichen phosphatidylcholin-produkten
DE3047011A1 (de) * 1980-12-13 1982-07-22 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von oel und/oder phosphatidylethanolamin aus diese enthaltenden alkoholloeslichen phosphatidylcholin-produkten
DE3047012A1 (de) * 1980-12-13 1982-07-22 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von acylierten phospholipiden aus diese enthaltenden phosphatidylcholin-produkten
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
US4434163A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Water-soluble benzothiazine dioxide salts
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten

Also Published As

Publication number Publication date
NO844889L (no) 1985-06-24
PT79649A (en) 1985-06-03
IN162327B (ko) 1988-04-30
EP0147735A2 (de) 1985-07-10
GR82545B (en) 1985-04-24
FI845019A0 (fi) 1984-12-19
FI83287B (fi) 1991-03-15
EG17137A (en) 1992-12-30
DD233076A5 (de) 1986-02-19
EP0147735B1 (de) 1989-02-15
IL73849A0 (en) 1985-03-31
DE3346526A1 (de) 1985-07-04
NZ210648A (en) 1988-04-29
JPH0112729B2 (ko) 1989-03-02
ZA849976B (en) 1985-08-28
ES538982A0 (es) 1987-07-16
PH21823A (en) 1988-03-04
FI83287C (fi) 1991-06-25
AU566974B2 (en) 1987-11-05
ATE40793T1 (de) 1989-03-15
HUT35958A (en) 1985-08-28
KR920003602B1 (ko) 1992-05-04
AU3668584A (en) 1985-06-27
DE3346526C2 (de) 1986-12-11
HU193729B (en) 1987-11-30
FI845019L (fi) 1985-06-23
KR850004395A (ko) 1985-07-15
MX159874A (es) 1989-09-25
DE3476734D1 (en) 1989-03-23
EP0147735A3 (en) 1985-11-27
IL73849A (en) 1988-07-31
OA07907A (en) 1986-11-20
CA1234049A (en) 1988-03-15
ES8707111A1 (es) 1987-07-16
DK619484D0 (da) 1984-12-21
US4687766A (en) 1987-08-18
NO166569B (no) 1991-05-06
DK619484A (da) 1985-06-23
PT79649B (en) 1986-10-21
JPS60169420A (ja) 1985-09-02

Similar Documents

Publication Publication Date Title
DE3687224D1 (de) Hemmung vom 5-lipoxygenase-weg.
IT1177553B (it) Composti farmacologicamente attivi per il trattamento di affezioni gastrointestinali e procedimento di preparazione
NO160579C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-(1,4,5-trifenylimidazol-2-yloksy)-alkansyrer og disses derivater.
DE3377063D1 (en) Benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
NO166569C (no) Fremgangsmaate til fremstilling av farmasoeytisk preparat inneholdende fosfolipider og ikke-steroidale antiflogistika.
DK162439C (da) Imidazol-2-ylthioalkansyrer og derivater deraf, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
IT8348294A0 (it) Composti e composizioni per il trattamento delle affezioni cardiocircolatorie e procedimento di preparazione
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
DE3371515D1 (en) Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
IT1095015B (it) Derivato furanico per impiego quale prodotto farmaceutico particolarmente per il trattamento di malattie reumatiche e metodo per la sua preparazione
PT87555A (pt) Process for the preparation and isolation of human splein and of pharmaceutical compounds containing it
IT7945204A0 (it) Composizione farmaceutica per la terapia delle sterilita' maschile